Global Self-expanding Metal Stents Market Size By Type (Stainless Steel Stents, Nitinol Stents), By Application (Hospitals, Ambulatory Surgery Centers (ASCs)), By Region, And Segment Forecasts, 2023 t...

The Global Self-expanding Metal Stents Market was valued at USD 4.1 billion in 2023 and is projected to surpass USD 7.3 billion by 2031, expanding at a CAGR of 7.2% during the forecast period from 2023 to 2031. The market is driven by the rising prevalence of chronic cardiovascular and gastrointestinal diseases, technological advancements in stent materials and deployment systems, and the increasing adoption of minimally invasive procedures. Self-expanding metal stents (SEMS) are widely utilized in treating conditions like peripheral artery disease, biliary obstructions, and esophageal strictures, offering enhanced flexibility, patency, and patient outcomes.

Drivers:

1. Rising Incidence of Cardiovascular and Gastrointestinal Disorders:

The growing global burden of atherosclerosis, colorectal cancer, and other obstructive conditions has significantly increased the demand for SEMS, particularly among aging populations and high-risk patient groups.

2. Surge in Minimally Invasive Procedures:

The clinical preference for non-surgical treatments that reduce recovery time and hospital stay is fueling demand for self-expanding metal stents. These devices are preferred due to their ease of delivery and superior expansion properties compared to balloon-expandable alternatives.

3. Technological Innovations:

Advancements such as drug-eluting SEMS, biocompatible materials (e.g., nitinol), and delivery systems with improved navigation are contributing to wider adoption in both hospital and outpatient settings.

Restraints:

1. Risk of Stent Migration and Restenosis:

Despite benefits, SEMS can pose risks like migration or tissue ingrowth, particularly in gastrointestinal applications. These complications may require additional interventions, thus limiting market growth.

2. High Treatment Costs in Emerging Markets:

The cost associated with self-expanding metal stents and advanced deployment systems may be a barrier in low-income countries, where access to healthcare infrastructure remains limited.

Opportunity:

1. Expanding Applications in Oncology and Peripheral Artery Disease:

SEMS are increasingly being explored for palliative care in cancer-related obstructions and for complex vascular interventions, offering untapped growth potential.

2. Rapid Market Expansion in Asia-Pacific:

Improved healthcare access, a growing geriatric population, and government initiatives in countries like China and India are creating robust opportunities for market players in the Asia-Pacific region.

Market by System Type Insights:

The Biliary Stents segment dominated the market in 2023, accounting for the largest revenue share. These stents are extensively used to relieve malignant biliary obstructions and have seen growing adoption in oncology departments. Meanwhile, the Esophageal Stents segment is expected to witness the fastest growth, owing to rising incidences of esophageal cancer and dysphagia among elderly patients.

Market by End-use Insights:

The Hospitals segment emerged as the leading end-user in 2023, supported by a high volume of interventional procedures and access to skilled healthcare professionals. However, Ambulatory Surgical Centers (ASCs) are projected to grow rapidly due to increased adoption of same-day procedures and advancements in portable imaging and deployment technologies.

Market by Regional Insights:

North America held the largest share of the self-expanding metal stents market in 2023, driven by well-established healthcare infrastructure, high disease prevalence, and early adoption of novel stent technologies. Asia-Pacific, however, is poised for the fastest growth during the forecast period, supported by rising healthcare investments, growing procedural volumes, and increasing awareness of endovascular therapies.

Competitive Scenario:

Leading players in the global self-expanding metal stents market include:

Boston Scientific Corporation

Medtronic plc

Cook Medical

Terumo Corporation

Micro-Tech (Nanjing) Co., Ltd.

Merit Medical Systems, Inc.

Taewoong Medical Co., Ltd.

Becton, Dickinson and Company

These companies are focusing on product innovations, geographical expansion, and mergers & acquisitions to reinforce their market presence. Notable developments include the introduction of stents with anti-migration coatings and biodegradable designs tailored for oncology and vascular use cases.

Scope of Work – Global Self-expanding Metal Stents Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 7.3 billion

CAGR (2023–2031) 7.2%

Market Segments By System Type (Biliary, Esophageal, Colonic, Vascular)